Same Indication

Ondansetron vs Upadacitinib

Ondansetron vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Ondansetron and Upadacitinib.

Mechanism of Action

Ondansetron: Selective 5-HT3 receptor antagonist.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Ondansetron — 3-5 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Ondansetron — C18H19N3O; Upadacitinib — C17H19F3N6O.

Molecular Weight: Ondansetron — 293.3660 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Ondansetron — Small molecule; Upadacitinib — Small molecule.